PMAQX | THCGX | PMAQX / THCGX | |
Total Expense Ratio | 0.60 | 1.42 | 42% |
Annual Report Gross Expense Ratio | 0.60 | 1.42 | 42% |
Fund Existence | 8 years | 24 years | - |
Gain YTD | -3.383 | -18.044 | 19% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 0 | 5000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 28.6B | 195M | 14,667% |
Annual Yield % from dividends | 0.20 | 0.00 | - |
Returns for 1 year | 8.21 | -8.87 | -93% |
Returns for 3 years | 20.32 | -4.75 | -428% |
Returns for 5 years | 65.92 | -32.23 | -205% |
Returns for 10 years | N/A | -10.72 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDOG | 30.92 | 0.09 | +0.29% |
ALPS International Sector Div Dogs ETF | |||
MINT | 100.22 | 0.01 | +0.01% |
PIMCO Enhanced Short Maturity Active ETF | |||
CLOI | 52.25 | -0.11 | -0.21% |
VanEck CLO ETF | |||
IDNA | 19.16 | -0.30 | -1.54% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
KOCG | 26.72 | -0.58 | -2.13% |
FIS Knights of Columbus Global Blf ETF |